Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against eph family receptors

• Monoclonal antibody therapy as a successful therapeutic strategy in many cancers.• High expression of Eph receptors on hematopoietic malignancies.• High specificity of Eph receptors on malignant hematopoietic cells.• Eph receptors as a target for antibody therapy in hematological malignanc ies. (Source: Experimental Hematology)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2v1MTqf
via IFTTT